RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA

Qi Wang,Yaxun Guo,Wentao Wang,Bingqi Liu,Guangsheng Yang,Zongzhen Xu,Jie Li,Zhiqian Liu
DOI: https://doi.org/10.1016/j.yexcr.2020.112453
IF: 4.145
2021-02-01
Experimental Cell Research
Abstract:<p>RNA-binding proteins (RBPs) closely regulate the whole lifecycle of most RNA molecules, from the very early stage of transcription to RNA decay. Dysregulation of RBPs significantly affects the fate of cancer-related transcripts. Therefore, it is imperative to fully understand the complicated RBP-RNA regulatory networks in malignant diseases and to explore novel therapeutic targets. The RBP DAZAP1 (deleted in azoospermia-associated protein 1), originally identified as an important protein in spermatogenesis, had rarely been studied in the context of carcinogenesis. The role of DAZAP1 in hepatocellular carcinoma (HCC) was unveiled in this study. The relative expression of DAZAP1 was significantly upregulated in HCC and was positively associated with several key malignant characteristics and poor postoperative survival in patients. DAZAP1 knockdown by small interfering RNA markedly inhibited HCC cell proliferation, migration and invasion. Furthermore, DAZAP1 significantly reduced cellular sensitivity to sorafenib (SF), which had been proven to be an inducer of ferroptosis by targeting the system Xc<sup>−</sup> (composed of a light chain, xCT/SLC7A11, and a heavy chain, 4F2 heavy chain). At the mechanistic level, DAZAP1 was identified as a potent inhibitor of ferroptosis and an efficient binding partner of <em>SLC7A1</em>1 mRNA. Further study revealed that DAZAP1 interacted with the 3′UTR (untranslated region) of <em>SLC7A1</em>1 mRNA and positively regulated its stability. In our work, we clarified novel functions of DAZAP1 and preliminarily revealed its underlying mechanism in ferroptosis, which may be conducive to the exploration of biomarkers and therapeutic targets in HCC patients.</p>
oncology,cell biology
What problem does this paper attempt to address?
The paper attempts to address the role of the RNA-binding protein DAZAP1 in hepatocellular carcinoma (HCC) and its regulatory mechanism on ferroptosis. Specifically, the researchers aim to answer the following questions: 1. **Expression of DAZAP1 in HCC and its relationship with clinical features**: - Is the expression of DAZAP1 significantly upregulated in HCC tissues? - Is the expression level of DAZAP1 associated with malignant characteristics of HCC patients (such as vascular invasion, tumor size, etc.) and prognosis? 2. **Impact of DAZAP1 on the biological behavior of HCC cells**: - Does knockdown or overexpression of DAZAP1 affect the proliferation, migration, and invasion abilities of HCC cells? 3. **Role of DAZAP1 in ferroptosis**: - Is DAZAP1 involved in sorafenib (SF)-induced ferroptosis? - Does DAZAP1 influence the sensitivity of cells to ferroptosis by regulating the expression of ferroptosis-related genes (such as SLC7A11)? 4. **Mechanism of DAZAP1 regulating the stability of SLC7A11 mRNA**: - Does DAZAP1 directly bind to the 3' untranslated region (3′UTR) of SLC7A11 mRNA? - Does this binding affect the stability of SLC7A11 mRNA, thereby influencing its expression level? Through these studies, the authors aim to reveal the novel functions of DAZAP1 in HCC and its potential molecular mechanisms, providing new targets for the diagnosis and treatment of HCC.